Cargando…
Antimalarials exert a cardioprotective effect in lupus patients: Insights from the Spanish Society of Rheumatology Lupus Register (RELESSER) analysis of factors associated with heart failure
BACKGROUND/OBJECTIVES: Factors associated with chronic heart failure (CHF) in patients with systemic lupus erythematosus (SLE) have received little attention. Recent data on the use of hydroxychloroquine in the treatment of SARS-CoV-2 infection have cast doubt on its cardiac safety. The factors asso...
Ejemplares similares
-
Cardiovascular Events in Systemic Lupus Erythematosus: A Nationwide Study in Spain From the RELESSER Registry
por: Fernández-Nebro, Antonio, et al.
Publicado: (2015) -
Primary respiratory disease in patients with systemic lupus erythematosus: data from the Spanish rheumatology society lupus registry (RELESSER) cohort
por: Narváez, Javier, et al.
Publicado: (2018) -
Comprehensive Description of Clinical Characteristics of a Large Systemic Lupus Erythematosus Cohort from the Spanish Rheumatology Society Lupus Registry (RELESSER) With Emphasis on Complete Versus Incomplete Lupus Differences
por: Rúa-Figueroa, Íñigo, et al.
Publicado: (2015) -
Characterization of Patients With Lupus Nephritis Included in a Large Cohort From the Spanish Society of Rheumatology Registry of Patients With Systemic Lupus Erythematosus (RELESSER)
por: Galindo-Izquierdo, María, et al.
Publicado: (2016) -
Hydroxychloroquine is associated with a lower risk of polyautoimmunity: data from the RELESSER Registry
por: Mena-Vázquez, Natalia, et al.
Publicado: (2020)